DEKA Biosciences

Germantown, MD · Founded 2019 · Privately Held (backing)

Operator of a biotechnology company intended to develop and deliver life-changing medicines for cancer and inflammatory diseases. DEKA Biosciences is based in Germantown, MD and was founded in 2019. It was valued at $36 million at its early-stage round in Feb 2023, the last priced event on record. It has raised $104 million across 2 recorded rounds; the latest was a $29.9 million early-stage round in Feb 2023.

PMV mark · valuation
$36.0M
Oct 2026
Priced at
its early-stage round
Feb 2023
Total raised
$104.2M
Last round
Early Stage VC
Feb 2023
What is DEKA Biosciences worth?
$36.0MPrivateMarketView mark · Oct 2026

Valued at $36.0M at its early-stage round, Feb 2023. Nothing has traded since.

Free account
More of DEKA Biosciences with a free account
  • ·Watch DEKA Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

DEKA Biosciences funding history

2 rounds
DateRoundRaisedPost-money
Feb 2023Early Stage VC$29.9M▮
Oct 2021Early Stage VC$15.9M▮
Unlock post-money valuations

Membership and data by Private Market View

DEKA Biosciences valuation

DEKA Biosciences was valued at $36 million at its early-stage round in Feb 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has DEKA Biosciences raised?

DEKA Biosciences has raised $104 million in total; 2 of its rounds are on record. The largest on record was a $29.9 million early-stage round in Feb 2023.

DEKA Biosciences has filed 2 Form Ds with the SEC since 2021, most recently in Dec 2023 ($29.9 million sold to 33 investors).

How DEKA Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For DEKA Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about DEKA Biosciences

What is DEKA Biosciences worth?
DEKA Biosciences is valued at $36.0M as of Oct 2026. Valued at $36.0M at its early-stage round, Feb 2023. Nothing has traded since.
How much has DEKA Biosciences raised?
DEKA Biosciences has raised $104.2M in total funding across 2 recorded rounds.
When did DEKA Biosciences last raise?
DEKA Biosciences last raised in Feb 2023 (Early Stage VC), raising $29.9M.